Its good to know that. Thank you
By the way is your TP able to flag 'new' creatinine result if there isn't a previous one?
A
________________________________________
From: ACB AKI-Detection-Algorithm [[log in to unmask]] on behalf of Richmond Katherine (RLZ) [[log in to unmask]]
Sent: 11 December 2014 16:24
To: [log in to unmask]
Subject: Re: Best practice guidance now available
Hi Ahmed
We have CSC Telepath and our initial validation highlighted this and
another couple of issues.
As of last week Telepath has put this right and all is now working and
we are ready to go live.
It should be just a matter of Telepath rolling this out.....
Kathy Richmond
Principal Biochemist
Royal Shrewsbury Hospital
SY3 8XQ
01743 261157
-----Original Message-----
From: ACB AKI-Detection-Algorithm
[mailto:[log in to unmask]] On Behalf Of Waise, Ahmed
Sent: 10 December 2014 15:37
To: [log in to unmask]
Subject: Re: Best practice guidance now available
thank you
the guide says:
'The AKI detection algorithm will produce a test result for every
creatinine result that is consistent with AKI; the test result is named
'AKI Warning Stage'. This test result will be a numerical field with
four possible variables: null, 1, 2 or 3. The null results will not be
reported, but results 1, 2, or 3 should be sent to your local results
reporting system/patient management system and set to flag as abnormal
as for all other biochemical test results.'
Any one else using CSC iSOFT telepath not being able to suppress the
'null result and stopping from appearing on reports? Its causing us a
headache with 'AKI=0' in EPR . We are waiting to hear from CSC.
regards
A
Ahmed Waise FRCP FRCPath
Consultant in Chemical Pathology & Metabolic Medicine
Department of Clinical Biochemistry
Poole Hospital NHSFT, Longfleet Road,
Poole, Dorset BH15 2JB
________________________________________
From: ACB AKI-Detection-Algorithm [[log in to unmask]] on
behalf of Hill Robert (NORTH BRISTOL NHS TRUST) [[log in to unmask]]
Sent: 02 December 2014 14:47
To: [log in to unmask]
Subject: Best practice guidance now available
---
This message was sent from an email address external to NHSmail but
gives the appearance of being from an NHSmail (@nhs.net) address. The
recipient should verify the sender and content before acting upon
information contained within.
The identified sender is [log in to unmask]
---
Best practice guidance for implementing the NHS England AKI algorithm is
now available on the new "think kidneys" website:
https://www.thinkkidneys.nhs.uk/wp-content/uploads/2014/12/AKI-Warning-A
lgorithm-Best-Practice-Guidance-final-publication-0112141.pdf
Dr Robert Hill
Consultant Clinical Biochemist
Chair NHS England AKI Programme, Detection Workstream
************************************************************************
********************************************
This message may contain confidential information. If you are not the
intended recipient please inform the
sender that you have received the message in error before deleting it.
Please do not disclose, copy or distribute information in this e-mail or
take any action in reliance on its contents:
to do so is strictly prohibited and may be unlawful.
Thank you for your co-operation.
NHSmail is the secure email and directory service available for all NHS
staff in England and Scotland
NHSmail is approved for exchanging patient data and other sensitive
information with NHSmail and GSi recipients
NHSmail provides an email address for your career in the NHS and can be
accessed anywhere
************************************************************************
********************************************
DISCLAIMER: This email and any files transmitted with it are
confidential and intended solely for the use of the individual,
individuals or entity to whom they are addressed. Any views or opinions
expressed are those of the author and do not necessarily represent the
views of Poole Hospital NHS Foundation Trust unless otherwise explicitly
stated. This email may contain confidential and/or privileged
materials. In the case of confidential and/or privileged materials, any
review, retransmission, dissemination or other use of these materials by
individuals or entities other than the intended recipient may be the
subject of legal action. If you receive an email in error from Poole
Hospital NHS Foundation Trust, please contact the sender and delete the
material from your computer.
DISCLAIMER: This email and any files transmitted with it are
confidential and intended solely for the use of the individual,
individuals or entity to whom they are addressed. Any views or opinions
expressed are those of the author and do not necessarily represent the
views of Poole Hospital NHS Foundation Trust unless otherwise explicitly
stated. This email may contain confidential and/or privileged
materials. In the case of confidential and/or privileged materials, any
review, retransmission, dissemination or other use of these materials by
individuals or entities other than the intended recipient may be the
subject of legal action. If you receive an email in error from Poole
Hospital NHS Foundation Trust, please contact the sender and delete the
material from your computer.
|
